In Hu et al.,39 Huang et al.,40 and Feng et al.41and meta‐analyses on the XRCC1 Arg194Trp polymorphism and risk of cancer, this polymorphism was identified as a biomarker of cancer risk. The gene discussed is XRCC1; the disease is cancer.